发明名称 |
Methods for inhibiting cell proliferation in EGFR-driven cancers |
摘要 |
Abstract The invention features a method for treating patients who have an EGFR-driven cancer, which is, or has become, refractory to a tyrosine kinase inhibitor, such as eriotinib and gefitinib, by administering a compound of formula (I) to the patient. The invention also features treating EGFR-driven cancers having an EGFR mutation identified herein. |
申请公布号 |
AU2013203904(A1) |
申请公布日期 |
2013.05.02 |
申请号 |
AU20130203904 |
申请日期 |
2013.04.11 |
申请人 |
ARIAD PHARMACEUTICLAS, INC. |
发明人 |
DALGARNO, DAVID C.;SHAKEPEARE, WILLIAM C.;ZHU, XIAOTIAN;RIVERA, VICTOR M.;MIRET, JUAN J. |
分类号 |
A01N43/54;A61K31/505 |
主分类号 |
A01N43/54 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|